Autoimmune autonomic ganglionopathy with reversible cognitive impairment

Archives of Neurology

Volumn 69, Issue 4, 2012, Pages 461-466

  Gibbons, Christopher H ^a   Centi, Justin ^a   Vernino, Steven ^b   Freeman, Roy ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; ATTENTION; AUTOIMMUNE AUTONOMIC GANGLIONOPATHY; AUTOIMMUNE DISEASE; CASE REPORT; CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE ASSOCIATION; EXECUTIVE FUNCTION; FEMALE; HUMAN; NEUROPATHY; NEUROPSYCHOLOGICAL TEST; ORTHOSTATIC HYPERTENSION; OUTCOME ASSESSMENT; PLASMAPHERESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; THERAPY EFFECT; UPREGULATION; WORKING MEMORY;

ANALYSIS OF VARIANCE; ANTIBODIES; ATTENTION; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; BLOOD PRESSURE; COHORT STUDIES; FEMALE; GANGLIA, AUTONOMIC; HEART RATE; HUMANS; HYPOTENSION, ORTHOSTATIC; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PLASMA EXCHANGE; PSYCHOMOTOR PERFORMANCE; RECEPTORS, CHOLINERGIC;

EID: 84859941678     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.2372     Document Type: Article

References (32)

1. Vernino S, Lindstrom J, Hopkins S, Wang Z, Low PA; Muscle Study Group. Characterization of ganglionic acetylcholine receptor autoantibodies. J Neuroimmunol. 2008;197(1):63-69.
2. Wang Z, Low PA, Jordan J, et al. Autoimmune autonomic ganglionopathy: IgG effects on ganglionic acetylcholine receptor current. Neurology. 2007;68(22):1917-1921. (Pubitemid 46848624)
3. Klein CM, Vernino S, Lennon VA, et al. The spectrum of autoimmune autonomic neuropathies. Ann Neurol. 2003;53(6):752-758. (Pubitemid 36622512)
4. Gibbons CH, Vernino SA, Kaufmann H, Freeman R. L-DOPS therapy for refractory orthostatic hypotension in autoimmune autonomic neuropathy. Neurology. 2005;65(7):1104-1106. (Pubitemid 41429640)
5. Vernino S, Hopkins S, Wang Z. Autonomic ganglia, acetylcholine receptor antibodies, and autoimmune ganglionopathy. Auton Neurosci . 2009;146(1-2):3-7.
6. Gibbons CH, Freeman R. Antibody titers predict clinical features of autoimmune autonomic ganglionopathy. Auton Neurosci. 2009;146(1-2):8-12.
7. Vernino S, Sandroni P, Singer W, Low PA. Autonomic ganglia: target and novel therapeutic tool. Neurology. 2008;70(20):1926-1932. (Pubitemid 351684647)
8. Gibbons CH, Vernino SA, Freeman R. Combined immunomodulatory therapy in autoimmune autonomic ganglionopathy. Arch Neurol. 2008;65(2):213-217. (Pubitemid 351240782)
9. Baker SK, Morillo C, Vernino S. Autoimmune autonomic ganglionopathy with lateonset encephalopathy. Auton Neurosci. 2009;146(1-2):29-32.
10. Flanagan EP, McKeon A, Lennon VA, et al. Autoimmune dementia: clinical course and predictors of immunotherapy response. Mayo Clin Proc . 2010;85(10):881-897.
11. McKeon A, Lennon VA, Lachance DH, Fealey RD, Pittock SJ. Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments. Arch Neurol. 2009;66(6):735-741.
12. Richardson JT. Measures of short-term memory: a historical review. Cortex. 2007; 43(5):635-650. (Pubitemid 47050643)
13. Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med. 2000;343(12):847-855.
14. Verghese J, Lipton RB, Hall CB, Kuslansky G, Katz MJ. Low blood pressure and the risk of dementia in very old individuals. Neurology. 2003;61(12):1667-1672. (Pubitemid 38020809)
15. Qiu C, von Strauss E, Fastbom J, Winblad B, Fratiglioni L. Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Arch Neurol. 2003;60(2):223-228. (Pubitemid 36193966)
16. Ballard C, O'Brien J, Barber B, et al. Neurocardiovascular instability, hypotensive episodes, and MRI lesions in neurodegenerative dementia. Ann N Y Acad Sci. 2000;903:442-445. (Pubitemid 30251586)
17. Eguchi K, Kario K, Hoshide S, et al. Greater change of orthostatic blood pressure is related to silent cerebral infarct and cardiac overload in hypertensive subjects. Hypertens Res. 2004;27(4):235-241. (Pubitemid 38594394)
18. Qiu CX, Winblad B, Fratiglioni L. Risk factors for dementia and Alzheimer's disease-findings from a community-based cohort study in Stockholm, Sweden [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi. 2005;26(11):882-887.
19. Robbins TW, James M, Lange KW, Owen AM, Quinn NP, Marsden CD. Cognitive performance in multiple system atrophy. Brain. 1992;115(pt 1):271-291.
20. Brown RG, Lacomblez L, Landwehrmeyer BG, et al NNIPPS Study Group. Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain. 2010;133(pt 8):2382-2393.
21. Poewe W. Dysautonomia and cognitive dysfunction in Parkinson's disease. Mov Disord. 2007;22(suppl 17):S374-S378. (Pubitemid 350134191)
22. Johns EK, Phillips NA, Belleville S, et al. Executive functions in frontotemporal dementia and Lewy body dementia. Neuropsychology. 2009;23(6):765-777.
23. Andersson M, Hansson O, Minthon L, Ballard CG, Londos E. The period of hypotension following orthostatic challenge is prolonged in dementia with Lewy bodies. Int J Geriatr Psychiatry. 2008;23(2):192-198. (Pubitemid 351308500)
24. Heims HC, Critchley HD, Martin NH, Jäger HR, Mathias CJ, Cipolotti L. Cognitive functioning in orthostatic hypotension due to pure autonomic failure. Clin Auton Res. 2006;16(2):113-120.
25. Benarroch EE. Acetylcholine in the cerebral cortex: effects and clinical implications. Neurology. 2010;75(7):659-665.
26. Levin ED, Torry D. Acute and chronic nicotine effects on working memory in aged rats. Psychopharmacology (Berl). 1996;123(1):88-97. (Pubitemid 26040256)
27. Levin ED, Conners CK, Silva D, et al. Transdermal nicotine effects on attention. Psychopharmacology (Berl). 1998;140(2):135-141. (Pubitemid 28538472)
28. Rushforth SL, Allison C, Wonnacott S, Shoaib M. Subtype-selective nicotinic agonists enhance olfactory working memory in normal rats: a novel use of the odour span task. Neurosci Lett. 2010;471(2):114-118.
29. Foulds J, Stapleton J, Swettenham J, Bell N, McSorley K, Russell MA. Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers. Psychopharmacology (Berl). 1996;127(1):31-38. (Pubitemid 26285680)
30. Levin ED, Conners CK, Sparrow E, et al. Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology (Berl). 1996;123(1):55-63.
31. Rezvani AH, Levin ED. Cognitive effects of nicotine. Biol Psychiatry. 2001;49(3):258-267. (Pubitemid 32178435)
32. Gianaros PJ, Van Der Veen FM, Jennings JR. Regional cerebral blood flow correlates with heart period and high-frequency heart period variability during working-memory tasks: implications for the cortical and subcortical regulation of cardiac autonomic activity. Psychophysiology. 2004;41(4):521-530. (Pubitemid 38879768)